Peptide-Based Drugs: Tackling Autoimmune Diseases with Precision Medicine
The global peptide therapeutics market is on the cusp of remarkable growth, projected to rise from US$ 37.8 billion in 2022 to more than US$ 85.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 9.6%. This surge can be attributed to various factors, including the increasing prevalence of chronic diseases, advancements in biotechnology, and the development of innovative...
0 Commenti 0 Condivisioni 455 Visualizzazioni